FDA to face questions about CBD rules from key congressional committee
The U.S. House Oversight Committee plans to grill Food and Drug Administration Commissioner Robert Califf about why the agency still hasn’t created CBD regulations.
Lawsuit: Generic drugmakers infringed on Epidiolex cannabis drug patents
Global pharma giant Jazz Pharmaceuticals filed a lawsuit alleging that a list of generic drug companies infringed on its patents for Epidiolex, a cannabis-derived drug used to treat seizures from Dravet syndrome, tuberous sclerosis complex and Lennox-Gastaut syndrome.
Google relaxes some advertising restrictions for hemp, CBD products
Google Ads will no longer ban all hemp and CBD advertising in California, Colorado and Puerto Rico, but there continue to be limitations to marketers.
USDA gives $5 million to expand hemp opportunities in Tennessee
Two universities, a hemp trade group and the agriculture department in Tennessee are joining forces to research and develop new economic opportunities for the state’s hemp industry.
10 marijuana industry trends to watch for in 2023
Here are the top 10 marijuana industry trends to watch for in 2022, as determined by MJBizDaily staffers.
2 major Canadian cannabis wholesalers put brakes on delta-8 THC products
Cannabis wholesalers in Ontario and British Columbia – two major Canadian adult-use marijuana markets – are suspending orders of products containing delta-8 THC.
USDA extends deadline for DEA-approved lab tests on hemp by one year
The U.S. Department of Agriculture is giving hemp cultivators one more year to secure a lab that is registered with the Drug Enforcement Administration to test products.
